Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Medicine
•
General Geriatric Medicine
What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?
Related Questions
How do you counsel older adults regarding the use of melatonin (dose and timing) for sleep-related problems?
How do you counsel older adults regarding the use, dosing, and safety of CBD-containing products for insomnia?
How do you counsel older patients on taking melatonin versus Ramelteon?
Should we be recommending a specific daily protein intake to prevent sarcopenia in geriatrics patients, or do you find it more beneficial to focus on encouraging activity within their mobility limitations to preserve muscle mass?
In outpatient primary care settings, would you recommend routinely checking Cystatin-C as a marker of renal function in older adults?
What is your antipsychotic of choice and general titration regimen in the outpatient setting for a patient with dementia and behavioral disturbances (assuming reversible causes such as urinary retention, constipation, etc. have been addressed)?
How do you approach the management of insulin-dependent diabetes in older adults with difficulty adhering to therapy?
How do you approach Vitamin D testing and supplementation in older adults following a fragility fracture?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
What is the role of antibiotic suppression for the prevention of frequent UTIs in older adult patients?
